A5014986381- Lung Cancer Treatments and Mutations
- Neuroendocrine Tumor Research Advances
- Clinical practice guidelines implementation
- Global Public Health Policies and Epidemiology
- Lung Cancer Research Studies
- Cardiovascular Health and Risk Factors
Henan Cancer Hospital
2024
Zhengzhou University
2024
The transformation of lung adenocarcinoma to small cell cancer (SCLC) is a recognized resistance mechanism and hindrance therapies using epidermal growth factor receptor tyrosine kinase inhibitors (TKIs). paucity pretranslational/posttranslational clinical samples limits the deeper understanding mechanisms exploration effective therapeutic strategies. Here, we developed preclinical neuroendocrine (NE) models. Next, identified transcriptional reprogramming that drives erlotinib in NE lines...
Objective: To understand the current situation on management of diabetes mellitus patients aged 35 and above in National Demonstration Areas for Comprehensive Prevention Control Non-communicable Diseases, China. Methods: Local residents, 18 years were randomly selected by a complex, multistage, probability sampling method. Face-to-face questionnaire survey was carried out between November December 2016. Rates regarding prevalence, treatment calculated, influencing factors analyzed using...